KDIGO is developing an update to the 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (CKD). The update to the CKD Guideline is intended for healthcare professionals involved in the provision of kidney care, people with suspected or diagnosed CKD and their carers, as well as policymakers and commissioners of CKD services. The aim is to generate a useful resource that clearly and concisely addresses relevant questions with actionable recommendations and tackles controversial topics where there is sufficient evidence. Dr. Adeera Levin (Canada) and Dr. Paul Stevens (United Kingdom) will co-chair the guideline.
The development of this guideline will follow an explicit process of evidence review and appraisal. Treatment approaches are addressed in each chapter and guideline recommendations are based on systematic reviews of relevant trials. Practical comments or statements which serve as educational purposes are ungraded, but included as important information for the readership. Appraisal of the quality of the evidence and the strength of recommendations followed the GRADE approach. Ongoing areas of controversies, limitations of the evidence, and international relevance will be discussed and additional suggestions will be provided for future research.
COMMENTARIES
Canadian Society of Nephrology
Commentary on the KDIGO Clinical Practice Guideline for CKD Evaluation and Management
KDOQI
US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD
CSMBLM and CCMB
The role of laboratory testing in detection and classification of chronic kidney disease: national recommendations
The Lancet
The Global Issue of Kidney Disease
Volume 382, Issue 9887
13 July, 2013
The Lancet
Evolving Importance of Kidney Disease: From Subspecialty to Global Health Burden
Volume 382, Issue 9887
13 July 2013
DISCLAIMER: USE OF THE CLINICAL PRACTICE GUIDELINES
This Clinical Practice Guideline is based upon the best information available at the time of publication. The recommendations are designed to provide information and assist decision-making. They are not intended to define a standard of care, and should not be construed as one. Neither should they be interpreted as prescribing an exclusive course of management. Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every health care professional making use of this Guideline is responsible for evaluating the appropriateness of applying them in the setting of any particular clinical situation. The recommendations for research contained within this document are general and do not imply a specific protocol.
